FDA Inspection 640564 — Charles Redfern, MD

Charles Redfern, MD — FEI 3008034021

The FDA completed an inspection of Charles Redfern, MD on Jan 15, 2010 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 15, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance